Cargando…

Spectrum of Eye Disease in Diabetes (SPEED) in India: A prospective facility-based study. Report # 4. Glaucoma in people with type 2 diabetes mellitus

PURPOSE: To estimate the proportion of people with type 2 diabetes mellitus (T2DM) and glaucoma in a facility-based cross-sectional observational study in India. METHODS: All people received a comprehensive eye examination. Glaucoma-specific examinations included applanation tonometry, optic disc an...

Descripción completa

Detalles Bibliográficos
Autores principales: Behera, Umesh C, Bhattacharjee, Harsha, Das, Taraprasad, Gilbert, Clare, Murthy, G V S, Rajalakshmi, R, Pant, Hira B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7001170/
https://www.ncbi.nlm.nih.gov/pubmed/31937726
http://dx.doi.org/10.4103/ijo.IJO_1948_19
_version_ 1783494183204421632
author Behera, Umesh C
Bhattacharjee, Harsha
Das, Taraprasad
Gilbert, Clare
Murthy, G V S
Rajalakshmi, R
Pant, Hira B
author_facet Behera, Umesh C
Bhattacharjee, Harsha
Das, Taraprasad
Gilbert, Clare
Murthy, G V S
Rajalakshmi, R
Pant, Hira B
author_sort Behera, Umesh C
collection PubMed
description PURPOSE: To estimate the proportion of people with type 2 diabetes mellitus (T2DM) and glaucoma in a facility-based cross-sectional observational study in India. METHODS: All people received a comprehensive eye examination. Glaucoma-specific examinations included applanation tonometry, optic disc and cup evaluation, and stereo biomicroscopy in all people; gonioscopy and visual field testing in glaucoma suspects. The International Society of Geographic and Epidemiologic Ophthalmology guidelines were used to diagnose and classify glaucoma. RESULTS: The study recruited 11,182 people (average age: 58.2 ± 10.6; range 39–96 years). Glaucoma was diagnosed in 4.9% (n = 547) people. About 76.8% (n = 420) of those with glaucoma had bilateral disease, and 98.7% (n = 540) were >40 years. Among people with bilateral disease, 94.5% (n = 397) had primary glaucoma – open angle in 59.3% (n = 228) and angle closure in 40.2% (n = 169). Diabetes duration was ≤10 years in 71.5% (n = 300) people. On linear regression, the following were associated with glaucoma: advancing age [compared with <40 years age group; odds ratio [OR] in 50-60 year age group: 1.36 [95% confidence interval (CI): 1.01–1.8], P < 0.035); >60 years age group (OR: 2.05, 95% CI: 1.57–2.67; P < 0.001), and diabetic neuropathy (OR: 2.62, 95% CI: 1.35–5.10, P < 0.003). Glycemic control did not have significant association (P = 0.425). CONCLUSION: Presence of glaucoma in people with T2DM in this cohort was similar to the general population prevalence studies in India. Glaucoma was invariably bilateral. A comprehensive eye examination in people age 40 years and older with diabetes and/or glaucoma is beneficial.
format Online
Article
Text
id pubmed-7001170
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-70011702020-02-13 Spectrum of Eye Disease in Diabetes (SPEED) in India: A prospective facility-based study. Report # 4. Glaucoma in people with type 2 diabetes mellitus Behera, Umesh C Bhattacharjee, Harsha Das, Taraprasad Gilbert, Clare Murthy, G V S Rajalakshmi, R Pant, Hira B Indian J Ophthalmol Original Article PURPOSE: To estimate the proportion of people with type 2 diabetes mellitus (T2DM) and glaucoma in a facility-based cross-sectional observational study in India. METHODS: All people received a comprehensive eye examination. Glaucoma-specific examinations included applanation tonometry, optic disc and cup evaluation, and stereo biomicroscopy in all people; gonioscopy and visual field testing in glaucoma suspects. The International Society of Geographic and Epidemiologic Ophthalmology guidelines were used to diagnose and classify glaucoma. RESULTS: The study recruited 11,182 people (average age: 58.2 ± 10.6; range 39–96 years). Glaucoma was diagnosed in 4.9% (n = 547) people. About 76.8% (n = 420) of those with glaucoma had bilateral disease, and 98.7% (n = 540) were >40 years. Among people with bilateral disease, 94.5% (n = 397) had primary glaucoma – open angle in 59.3% (n = 228) and angle closure in 40.2% (n = 169). Diabetes duration was ≤10 years in 71.5% (n = 300) people. On linear regression, the following were associated with glaucoma: advancing age [compared with <40 years age group; odds ratio [OR] in 50-60 year age group: 1.36 [95% confidence interval (CI): 1.01–1.8], P < 0.035); >60 years age group (OR: 2.05, 95% CI: 1.57–2.67; P < 0.001), and diabetic neuropathy (OR: 2.62, 95% CI: 1.35–5.10, P < 0.003). Glycemic control did not have significant association (P = 0.425). CONCLUSION: Presence of glaucoma in people with T2DM in this cohort was similar to the general population prevalence studies in India. Glaucoma was invariably bilateral. A comprehensive eye examination in people age 40 years and older with diabetes and/or glaucoma is beneficial. Wolters Kluwer - Medknow 2020-02 2020-01-17 /pmc/articles/PMC7001170/ /pubmed/31937726 http://dx.doi.org/10.4103/ijo.IJO_1948_19 Text en Copyright: © 2020 Indian Journal of Ophthalmology http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Behera, Umesh C
Bhattacharjee, Harsha
Das, Taraprasad
Gilbert, Clare
Murthy, G V S
Rajalakshmi, R
Pant, Hira B
Spectrum of Eye Disease in Diabetes (SPEED) in India: A prospective facility-based study. Report # 4. Glaucoma in people with type 2 diabetes mellitus
title Spectrum of Eye Disease in Diabetes (SPEED) in India: A prospective facility-based study. Report # 4. Glaucoma in people with type 2 diabetes mellitus
title_full Spectrum of Eye Disease in Diabetes (SPEED) in India: A prospective facility-based study. Report # 4. Glaucoma in people with type 2 diabetes mellitus
title_fullStr Spectrum of Eye Disease in Diabetes (SPEED) in India: A prospective facility-based study. Report # 4. Glaucoma in people with type 2 diabetes mellitus
title_full_unstemmed Spectrum of Eye Disease in Diabetes (SPEED) in India: A prospective facility-based study. Report # 4. Glaucoma in people with type 2 diabetes mellitus
title_short Spectrum of Eye Disease in Diabetes (SPEED) in India: A prospective facility-based study. Report # 4. Glaucoma in people with type 2 diabetes mellitus
title_sort spectrum of eye disease in diabetes (speed) in india: a prospective facility-based study. report # 4. glaucoma in people with type 2 diabetes mellitus
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7001170/
https://www.ncbi.nlm.nih.gov/pubmed/31937726
http://dx.doi.org/10.4103/ijo.IJO_1948_19
work_keys_str_mv AT beheraumeshc spectrumofeyediseaseindiabetesspeedinindiaaprospectivefacilitybasedstudyreport4glaucomainpeoplewithtype2diabetesmellitus
AT bhattacharjeeharsha spectrumofeyediseaseindiabetesspeedinindiaaprospectivefacilitybasedstudyreport4glaucomainpeoplewithtype2diabetesmellitus
AT dastaraprasad spectrumofeyediseaseindiabetesspeedinindiaaprospectivefacilitybasedstudyreport4glaucomainpeoplewithtype2diabetesmellitus
AT gilbertclare spectrumofeyediseaseindiabetesspeedinindiaaprospectivefacilitybasedstudyreport4glaucomainpeoplewithtype2diabetesmellitus
AT murthygvs spectrumofeyediseaseindiabetesspeedinindiaaprospectivefacilitybasedstudyreport4glaucomainpeoplewithtype2diabetesmellitus
AT rajalakshmir spectrumofeyediseaseindiabetesspeedinindiaaprospectivefacilitybasedstudyreport4glaucomainpeoplewithtype2diabetesmellitus
AT panthirab spectrumofeyediseaseindiabetesspeedinindiaaprospectivefacilitybasedstudyreport4glaucomainpeoplewithtype2diabetesmellitus
AT spectrumofeyediseaseindiabetesspeedinindiaaprospectivefacilitybasedstudyreport4glaucomainpeoplewithtype2diabetesmellitus